参考文献/References:
[1]Rampidis GP,Benetos G,Benz DC,et al.A guide for Gensini Score calculation[J].Atherosclerosis,2019,287:181-183.[2]中华医学会心血管病学分会,中国康复医学会心脏预防与康复专业委员会,中国老年学和老年医学会心脏专业委员会,等.中国心血管病一级预防指南[J].中华心血管病杂志,2020,48(12):1000-1038.[3]王增武,刘静,李建军,等.中国血脂管理指南(2023年)[J].中国循环杂志,2023,38(3):237-271.[4]Mach F,Baigent C,Catapano AL,et al.2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk[J].Eur Heart J,2020,41(1):111-188. [5]Visseren FLJ,Mach F,Smulders YM,et al.2021 ESC Guidelines on cardiovascular disease prevention in clinical practice[J].Eur Heart J,2021,42(34):3227-3337. [6]Wilson PWF,Jacobson TA,Martin SS,et al.Lipid measurements in the management of cardiovascular diseases: Practical recommendations a scientific statement from the national lipid association writing group[J].J Clin Lipidol,2021,15(5):629-648. [7]Ben-Aicha S,Badimon L,Vilahur G.Advances in HDL: Much More than Lipid Transporters[J].Int J Mol Sci,2020,21(3):732.[8]Aday AW,Lawler PR,Cook NR,et al.Lipoprotein Particle Profiles, Standard Lipids, and Peripheral Artery Disease Incidence[J].Circulation,2018,138(21):2330-2341. [9]Sniderman AD,Couture P,Martin SS,et al.Hypertriglyceridemia and cardiovascular risk: a cautionary note about metabolic confounding[J].J Lipid Res,2018,59(7):1266-1275. [10]Cantey EP,Wilkins JT.Discordance between lipoprotein particle number and cholesterol content: an update[J].Curr Opin Endocrinol Diabetes Obes,2018,25(2):130-136. [11]Allan D.Sniderman, Michael Pencina, George Thanassoulis, et al.ApoB:The Power of Physiology to Transform the Prevention of Cardiovascular Disease[J].Circulation Research,2019,124:1425-1427.[12]吴信辉,杨建敏,楼朝臣.载脂蛋白AⅠ/载脂蛋白B、可溶性糖基化终产物受体和几丁质酶-3样蛋白1与H型高血压患者冠状动脉病变程度的关系[J].中华高血压杂志,2022,30(10):985-989.[13]王宏宇,付茜,苏福祥.载脂蛋白B/载脂蛋白A1比值与急性冠脉综合征患者冠状动脉多支病变及斑块易损性的相关性[J].中国医科大学学报,2022,51(7):577-582.[14]Bi Q,Goodman KE,Kaminsky J,et al.What is Machine Learning? A Primer for the Epidemiologist[J].American Journal of Epidemiology,2019,188(12):2222-2239.[15]Madsen CM,Varbo A,Nordestgaard BG.Unmet need for primary prevention in individuals with hypertriglyceridaemia not eligible for statin therapy according to European Society of Cardiology/European Atherosclerosis Society guidelines: a contemporary population-based study[J].Eur Heart J,2018,39(7):610-619. [16]Bhatt DL,Steg PG,Miller M,et al.Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia[J].N Engl J Med,2019,380(1):11-22.[17]Marston NA,Giugliano RP,Im K,et al.Association Between Triglyceride Lowering and Reduction of Cardiovascular Risk Across Multiple Lipid-Lowering Therapeutic Classes: A Systematic Review and Meta-Regression Analysis of Randomized Controlled Trials[J].Circulation,2019,140(16):1308-1317. [18]Mehta A,Virani SS,Ayers CR,et al.Lipoprotein(a) and Family History Predict Cardiovascular Disease Risk[J].J Am Coll Cardiol,2020,76:781-793.[19]Burgess S,Ference BA,Staley JR,et al.Association of LPA Variants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies:A Mendelian Randomization Analysis[J].JAMA Cardiol,2018,3(7):619-627. [20]Lamina C,Kronenberg F,Lp(a)-GWAS-Consortium.Estimation of the Required Lipoprotein(a)-Lowering Therapeutic Effect Size for Reduction in Coronary Heart Disease Outcomes:A Mendelian Randomization Analysis[J].JAMA Cardiol,2019,4(6):575-579. [21]Hu X,Cristino J,Gautam R,et al.Characteristics and lipid lowering treatment patterns in patients tested for lipoprotein(a): A real-world US study[J].Am J Prev Cardiol,2023,14:100476.
相似文献/References:
[1]周 阳,王 妮,黄艳群,等.基于社区居民健康大数据预测高血压的患病风险[J].医学信息,2020,33(06):1.[doi:10.3969/j.issn.1006-1959.2020.06.001]
ZHOU Yang,WANG Ni,HUANG Yan-qun,et al.Risk of Hypertension Based on Big Data of Community Residents’ Health[J].Journal of Medical Information,2020,33(01):1.[doi:10.3969/j.issn.1006-1959.2020.06.001]
[2]朱 光,邓弘林.大数据背景下医院门诊挂号预约爽约行为预测研究[J].医学信息,2020,33(22):13.[doi:10.3969/j.issn.1006-1959.2020.22.004]
ZHU Guang,DENG Hong-lin.An Investigation of Predicting Patient Missing Appointment Behavior Under the Big Data Background[J].Journal of Medical Information,2020,33(01):13.[doi:10.3969/j.issn.1006-1959.2020.22.004]
[3]李言生,龚后武,栗翊超,等.基于真实世界数据的疾病风险预测研究[J].医学信息,2020,33(23):17.[doi:10.3969/j.issn.1006-1959.2020.23.006]
LI Yan-sheng,GONG Hou-wu,LI Yi-chao,et al.Research on Disease Risk Prediction Based on Real World Data[J].Journal of Medical Information,2020,33(01):17.[doi:10.3969/j.issn.1006-1959.2020.23.006]
[4]佟金铎,郭凤英,翟 兴,等.基于用户画像的患者就医影响因素研究[J].医学信息,2021,34(02):11.[doi:10.3969/j.issn.1006-1959.2021.02.004]
TONG Jin-duo,GUO Feng-ying,ZHAI Xing,et al.Study on the Influencing Factors of Patient Medical Treatment Based on User Portrait[J].Journal of Medical Information,2021,34(01):11.[doi:10.3969/j.issn.1006-1959.2021.02.004]
[5]郑 阳.医疗人工智能的关键技术及应用[J].医学信息,2021,34(02):19.[doi:10.3969/j.issn.1006-1959.2021.02.006]
ZHENG Yang.Key Technology and Application of Medical Artificial Intelligence[J].Journal of Medical Information,2021,34(01):19.[doi:10.3969/j.issn.1006-1959.2021.02.006]
[6]李 轩,王子为,赵靖萱,等.肿瘤预后预测领域机器学习应用的文献计量与热点可视化分析[J].医学信息,2022,35(09):90.[doi:10.3969/j.issn.1006-1959.2022.09.023]
LI Xuan,WANG Zi-wei,ZHAO Jing-xuan,et al.Visualization Analysis on Bibliometrics and Hot Spots of Machine Learning Applications in the Field of Tumor Prognosis Prediction[J].Journal of Medical Information,2022,35(01):90.[doi:10.3969/j.issn.1006-1959.2022.09.023]
[7]富 坤,李佳宁.LncRNA-疾病关联预测方法研究[J].医学信息,2023,36(04):166.[doi:10.3969/j.issn.1006-1959.2023.04.036]
FU Kun,LI Jia-ning.Research on LncRNA-disease Association Prediction Method[J].Journal of Medical Information,2023,36(01):166.[doi:10.3969/j.issn.1006-1959.2023.04.036]
[8]凌 天,焦 阳,狄碧云,等.面向机器学习的智慧诊疗语料库构建研究[J].医学信息,2023,36(10):6.[doi:10.3969/j.issn.1006-1959.2023.10.002]
LING Tian,JIAO Yang,DI Bi-yun,et al.Research on the Construction of Intelligent Diagnosis and Treatment Corpus for Machine Learning[J].Journal of Medical Information,2023,36(01):6.[doi:10.3969/j.issn.1006-1959.2023.10.002]
[9]段永飞,高继学,倪建鑫,等.基于人工智能学习模型在结节性硬化症相关肾血管平滑肌脂肪瘤诊疗中的研究[J].医学信息,2023,36(11):171.[doi:10.3969/j.issn.1006-1959.2023.11.037]
DUAN Yong-fei,GAO Ji-xue,NI Jian-xin,et al.Research on the Diagnosis and Treatment of Tuberous Sclerosis Complex-associated Renal Angiomyolipoma Based on Artificial Intelligence Learning Model[J].Journal of Medical Information,2023,36(01):171.[doi:10.3969/j.issn.1006-1959.2023.11.037]